What lab tests monitor efforts to extend lifespan?
The lab tests that actually help you monitor whether your efforts are working are the ones where the result tells you to do something specific: blood pressure, a lipid panel (especially ApoB or LDL), HbA1c and fasting glucose, and kidney and liver function tests all have clear treatment thresholds and established evidence linking treatment to reduced risk. Inflammatory markers like CRP add useful but more modest extra information. Popular 'biological age' tests based on DNA can show a number changing over time, but there's no established rule for what to do differently based on that number, which limits how useful they actually are for monitoring progress.
A lab test genuinely monitors progress toward extending lifespan only if the result can change a decision — a treatment, a habit, a referral — and this ranking applies that standard rather than ranking on panel size or novelty. Blood pressure, checked regularly at home or in clinic, ranks first, since it is the single risk factor with the largest randomised trial evidence for treatable mortality reduction and directly informs treatment decisions. A lipid panel, particularly ApoB or LDL cholesterol, ranks second, with strong trial evidence linking treatment to reduced cardiovascular events, and a result that directly informs whether medication is warranted. HbA1c and fasting glucose rank third, identifying prediabetes and diabetes early enough for intervention to meaningfully change trajectory, with clear treatment thresholds. Kidney and liver function tests rank fourth, since both affect medication safety and dosing and can reveal early, treatable dysfunction. High-sensitivity CRP and other inflammatory markers rank fifth, with real but more modest evidence for informing cardiovascular risk stratification in specific situations, used as an adjunct rather than a primary decision-maker. At the bottom of usefulness for actually monitoring lifespan-extension efforts sit popular 'biological age' tests based on DNA methylation or other novel biomarkers, which can track a number changing over time but have no established treatment threshold and no trial showing that acting on the number changes any outcome — the number moves, and it is genuinely unclear what, if anything, should be done differently as a result.
- A test is useful for monitoring lifespan efforts only if the result can change a specific decision.
- Blood pressure and lipid panels have the strongest link between the test result and an actionable treatment decision.
- HbA1c and kidney/liver function have clear, well-established treatment thresholds.
- Inflammatory markers add real but modest, adjunctive information.
- Biological age tests can show a changing number with no established action attached to that change.
Lab tests ranked by whether the result changes a decision
Ranked on: whether the test result is linked to an established treatment threshold and evidence that acting on it changes lifespan-relevant risk.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Blood pressure | The largest treatable mortality risk factor, with a clear result and threshold | GRADE AEstablished |
| 2 | Lipid panel (ApoB or LDL cholesterol) | A clear result linked to a treatment decision with strong trial evidence | GRADE AEstablished |
| 3 | HbA1c and fasting glucose | Identifies prediabetes and diabetes early enough to act | GRADE AEstablished |
| 4 | Kidney and liver function | Affects medication safety and reveals early, treatable dysfunction | GRADE BPromising |
| 5 | High-sensitivity CRP and other inflammatory markers | Real but modest, adjunctive value for risk stratification | GRADE BPromising |
| 6 | 'Biological age' tests (DNA methylation and similar) | A changing number with no established action attached | GRADE DInsufficient or unsafe |
- 01
Blood pressure
GRADE AEstablishedThe largest treatable mortality risk factor, with a clear result and thresholdRegular blood pressure monitoring, whether at home or in clinic, directly informs treatment decisions with extensive randomised trial evidence linking treatment to reduced stroke and cardiovascular death, making it one of the highest-value, lowest-cost tests available.
- 02
Lipid panel (ApoB or LDL cholesterol)
GRADE AEstablishedA clear result linked to a treatment decision with strong trial evidenceElevated ApoB or LDL cholesterol has a well-established treatment threshold, and randomised trials of cholesterol-lowering medication show reduced cardiovascular events, making this test's result directly actionable rather than merely descriptive.
- 03
HbA1c and fasting glucose
GRADE AEstablishedIdentifies prediabetes and diabetes early enough to actClear, established thresholds for prediabetes and diabetes allow intervention — lifestyle change or medication — early enough to meaningfully change trajectory, with strong evidence that earlier intervention improves outcomes compared with delayed diagnosis.
- 04
Kidney and liver function
GRADE BPromisingAffects medication safety and reveals early, treatable dysfunctionThese tests inform medication dosing and safety directly and can reveal early kidney or liver dysfunction while still treatable, making them relevant both to general health monitoring and to the safety of any other interventions being pursued.
- 05
High-sensitivity CRP and other inflammatory markers
GRADE BPromisingReal but modest, adjunctive value for risk stratificationUsed in specific situations to refine cardiovascular risk estimates alongside the tests above, with more modest and situation-dependent evidence than the primary tests, functioning best as an adjunct rather than a stand-alone decision-maker.
- 06
'Biological age' tests (DNA methylation and similar)
GRADE DInsufficient or unsafeA changing number with no established action attachedThese tests can show a numeric result changing over repeated measurements, but no established treatment threshold or trial evidence links a change in the number to a specific action or to improved outcomes, meaning the number moves without a clear answer to 'so what should I do differently'.
What each test tells you to do
Test result to action
| Test | Result that triggers action | Action |
|---|---|---|
| Blood pressure | Above threshold on repeated measurement | Lifestyle change and/or medication, per guideline |
| ApoB / LDL cholesterol | Above risk-based threshold | Statin or other lipid therapy per guideline, combined with risk assessment |
| HbA1c | In prediabetes or diabetes range | Lifestyle intervention and/or medication |
| Kidney function (eGFR) | Below normal range or declining trend | Investigation, medication adjustment, referral if indicated |
| hs-CRP | Elevated in the context of intermediate cardiovascular risk | May refine risk assessment and treatment decision alongside lipids |
| Biological age score | Number changes between tests | No established action currently exists |
Frequently asked questions
What lab tests actually monitor efforts to extend lifespan?
Ranked by whether the result changes a decision: blood pressure, a lipid panel (ApoB or LDL cholesterol), HbA1c and fasting glucose, kidney and liver function, and high-sensitivity CRP for risk refinement. Each has an established threshold and evidence linking treatment to reduced risk. Popular 'biological age' tests rank lowest because no established action follows from a change in the result.
Is a biological age test worth getting to track longevity progress?
It can show a numeric result changing between tests, but there is currently no established treatment threshold or trial evidence linking a change in the number to a specific action or to improved outcomes, which limits its usefulness for genuinely monitoring whether your efforts are working, compared with tests like blood pressure or a lipid panel.
Why is blood pressure ranked as the most important test to monitor?
Because it is the single risk factor with the largest randomised trial evidence for treatable mortality reduction, it is inexpensive and simple to measure regularly, and an abnormal result has a clear, well-established treatment pathway, making the connection between the test and an actionable decision as strong as any test on this list.
How often should I get these tests done?
This depends on your baseline results, age and risk factors, and is best determined with a doctor — blood pressure can be monitored more frequently at home, while blood tests like lipids and HbA1c are typically repeated annually or as advised based on results and any treatment changes.
What's wrong with tracking a comprehensive 'longevity panel' with many biomarkers?
Not all biomarkers in a comprehensive panel have an established treatment threshold or clear action attached to an abnormal result. The value of a test for monitoring lifespan-extension efforts specifically depends on whether the result changes what you or your doctor actually does, not on how many markers the panel includes.
Can inflammatory markers like CRP tell me if I'm aging well?
High-sensitivity CRP has real but modest, adjunctive value, mainly for refining cardiovascular risk assessment alongside primary tests like lipids and blood pressure in specific situations, rather than serving as a stand-alone measure of how well someone is ageing.
Keep reading
- What are the best longevity blood tests and biomarkers to monitor?
A fuller panel-level ranking of these same tests.
- What tests should a top longevity clinic provide?
The full tiered list of tests worth having.
- Which is the best longevity biological age test?
Where biological age tests stand on the evidence.
- Free stack check
How your medicines affect several of these test results.
More in Biomarkers & testing
- Which blood tests are best for tracking longevity?
ApoB, Lp(a), HbA1c, hs-CRP and a handful of others predict lifespan in large studies and cost little. Here is the core panel, what each marker means, and what to skip.
- Best longevity blood tests and biomarkers to monitor.
The monitoring guide: each longevity biomarker with its evidence-based target range, how often to retest, what moves it, and when a change means something rather than noise.
- VO2 max testing for longevity: what it measures, and what the evidence actually shows
VO2 max is one of the strongest predictors of all-cause mortality in the research. What the test actually measures, how accurate estimates are, and where to get one.
- Biological age tests: what they measure and what they miss
Epigenetic clocks are real science with real limits. What each test measures, how much your result can move between draws, and when it changes a decision.